3649 results for «480»

Filter By

3649 results

Clinical cases - Coronary interventions - Session 8

07 Oct 2022 – From AICT-AsiaPCR 2022

Top cases of AICT-AsiaPCR 2023

21 Sep 2023 – From AICT-AsiaPCR 2023

Discover the most intriguing cases featured at AICT-AsiaPCR 2023 in this session: from adrenaline surges to complex primary PCIs gone haywire, from CHIP protected PCI in AMICS to complex CTO of an anomalous RCA, dive into these real-world cases and gain valuable insights that expand your...

Top cases of AICT-AsiaPCR 2023

Learning - Percutaneous management of pulmonary embolism

22 Sep 2023 – From AICT-AsiaPCR 2023

Consult this session on percutaneous management of pulmonary embolism to learn about the indications for percutaneous pulmonary thrombectomy, to discover the techniques for performing this procedure, to gain insights into the various devices available, while exploring real-world case studies and staying updated on the latest clinical...

Learning - Percutaneous management of pulmonary embolism

Imaging solutions and innovative techniques in bifurcation lesions

22 Sep 2023 – From AICT-AsiaPCR 2023

Explore the complexities of bifurcation lesions through these presentations: learn how imaging can unravel the mysteries of ostial circumflex disease in previously stented LAD cases, discover innovative techniques, from DK crush to mini-culotte, in managing bailout double bifurcation scenarios, dive deep into the intricacies of jailed...

Imaging solutions and innovative techniques in bifurcation lesions

Three-year results of HOST-POLYTECH-ACS RCT comparing durable- vs. degradable-polymer DES

30 Aug 2023

Alex Sticchi provides his take on the 3-year results of HOST-POLYTECH-ACS RCT which were presented by Hyo-Soo Kim during the ESC 2023 congress in Amsterdam.

Alessandro Sticchi

Author

Alessandro Sticchi
Three-year results of HOST-POLYTECH-ACS RCT comparing durable- vs. degradable-polymer DES

Management of mitral regurgitation patients undergoing TMVI screening

13 Jan 2022

This study's results emphasise the strengths and limitations of transcatheter mitral valve implantation (TMVI) as a novel and promising therapy providing predictable elimination of MR in most patients, by S. Ludwig et al.

Management of mitral regurgitation patients undergoing TMVI screening

Primary Outcomes of a Pivotal Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Ballon with Conventional Ballon Angioplasty for In-Stent Restenosis (AGENT IDE)

27 Oct 2023

Mirvat Alasnag provides her take on the AGENT IDE trial which was presented by Robert W. Yeh at TCT Congress 2023. This pivotal randomized trial compares the safety and efficacy of the AGENT DCB to conventional balloon angioplasty in patients with ISR. It is the first...

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
Primary Outcomes of a Pivotal Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Ballon with Conventional Ballon Angioplasty for In-Stent Restenosis (AGENT IDE)

SIRONA completes enrollment! A leap in the DCB treatment of femoropopliteal arterial disease

02 Nov 2022

When transfemoral TAVI is not an option: rethinking alternative access strategies

18 Jun 2026

In this article, Ulrich Schäfer explores the evolving landscape of access strategies in transcatheter aortic valve implantation (TAVI). While the transfemoral approach remains the gold standard, a significant proportion of patients are not suitable due to peripheral vascular disease or anatomical constraints.
Drawing on clinical evidence and...

Author

Ulrich Schaefer
Alternative access, if transfemoral is not working
Didn’t find what you were looking for?